JPH11508590A - エナンチオマーが富化されたベンゾイミダゾール誘導体を光学的に精製する方法 - Google Patents
エナンチオマーが富化されたベンゾイミダゾール誘導体を光学的に精製する方法Info
- Publication number
- JPH11508590A JPH11508590A JP9505063A JP50506397A JPH11508590A JP H11508590 A JPH11508590 A JP H11508590A JP 9505063 A JP9505063 A JP 9505063A JP 50506397 A JP50506397 A JP 50506397A JP H11508590 A JPH11508590 A JP H11508590A
- Authority
- JP
- Japan
- Prior art keywords
- enantiomer
- benzimidazole
- methyl
- methoxy
- sulfinyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/28—Sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.(+)-エナンチオマーまたは(−)-エナンチオマーのいずれかが多い、式Ia 、Ib、Ic、IdおよびIe: の化合物の一つのエナンチオマーの富化された調製物を溶媒で処理し、この化 合物のラセミ化合物を溶媒から選択的に沈澱させ、沈澱したラ セミ化合物を濾過して除去し、続いて溶媒を除去して、式Ia〜Ieの対応する 化合物の光学的純度が増大した単一のエナンチオマーを得ることを特徴とする、 上記式Ia〜Ieの化合物の一つのエナンチオマーの富化された調製物を光学的 に精製する方法。 2.式Iaの化合物の(−)-エナンチオマーの光学的純度を増大することを特徴 とする請求項1記載の方法。 3.式Iaの化合物の(+)-エナンチオマーの光学的純度を増大することを特徴 とする請求項1記載の方法。 4.溶媒が蒸発によって除去される請求項1記載の方法。 5.エナンチオマーの富化された調製物が有機溶媒で処理される請求項1記載の 方法。 6.エナンチオマーの富化された調製物が有機溶媒の混合物で処理される請求項 1記載の方法。 7.エナンチオマーの富化された調製物が水と一つまたはそれ以上の有機溶媒と の混合物で処理される請求項1記載の方法。 8.水と一つまたはそれ以上の有機溶媒との混合物が50%より少ない水を含有す る請求項7記載の方法。 9.有機溶媒がアセトン、アセトニトリルまたはトルエンである請求項1記載の 方法。 10.調製される生成物が、(−)-5-メトキシ-2-〔〔(4-メトキシ-3,5-ジメチ ル-2-ピリジニル)-メチル〕スルフィニル〕-1H-ベンゾイミダゾールである請 求項1から9のいずれか1項に記載の方法。 11.調製される生成物が、(+)-5-メトキシ-2-〔〔(4-メトキシ-3,5-ジメチ ル-2-ピリジニル)-メチル〕スルフィニル〕-1H -ベンゾイミダゾールである請求項1から9のいずれか1項に記載の方法。 12.調製される生成物が、(−)-2-〔〔〔3-メチル-4-(2,2,2-トリフルオロエ トキシ)-2-ピリジニル)-メチル〕スルフィニル〕-1H-ベンゾイミダゾールで ある請求項1から9のいずれか1項に記載の方法。 13.調製される生成物が、(+)-2-〔〔〔3-メチル-4-(2,2,2-トリフルオロエ トキシ)-2-ピリジニル)-メチル〕スルフィニル〕-1H-ベンゾイミダゾールで ある請求項1から9のいずれか1項に記載の方法。 14.調製される生成物が、(−)-2-〔〔〔4-(3-メトキシプロポキシ)-3-メチ ル-2-ピリジニル)-メチル〕スルフィニル〕-1H-ベンゾイミダゾールである請 求項1から9のいずれか1項に記載の方法。 15.調製される生成物が、(+)-2-〔〔〔4-(3-メトキシプロポキシ)-3-メチ ル-2-ピリジニル)-メチル〕スルフィニル〕-1H-ベンゾイミダゾールである請 求項1から9のいずれか1項に記載の方法。 16.調製される生成物が、(−)-2-〔2-(N-イソブチル-N-メチルアミノ)ベン ジルスルフィニル〕-ベンゾイミダゾールである請求項1から9のいずれか1項 に記載の方法。 17.調製される生成物が、(+)-2-〔2-(N-イソブチル-N-メチルアミノ)ベン ジルスルフィニル〕-ベンゾイミダゾールである請求項1から9のいずれか1項 に記載の方法。 18.調製される生成物が、2-〔(4-メトキシ-6,7,8,9-テトラヒド ロ-5H-シクロヘプタ〔b〕ピリジン-9-イル)スルフィニル〕-1H-ベンゾイ ミダゾールの親油性のより高いジアステレオマーの単一のエナンチオマーの一つ である請求項1から9のいずれか1項に記載の方法。 19.調製される生成物が、2-〔(4-メトキシ-6,7,8,9-テトラヒドロ-5H-シク ロヘプタ〔b〕ピリジン-9-イル)スルフィニル〕-1H-ベンゾイミダゾールの 親油性のより低いジアステレオマーの単一のエナンチオマーの一つである請求項 1から9のいずれか1項に記載の方法。
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9500817 | 1995-07-03 | ||
| WO95/00817 | 1995-07-03 | ||
| PCT/SE1996/000841 WO1997002261A1 (en) | 1995-07-03 | 1996-06-26 | A process for the optical purification of enantiomerically enriched benzimidazole derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH11508590A true JPH11508590A (ja) | 1999-07-27 |
| JP4195507B2 JP4195507B2 (ja) | 2008-12-10 |
Family
ID=20397468
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP50506397A Expired - Lifetime JP4195507B2 (ja) | 1995-07-03 | 1996-06-26 | エナンチオマーが富化されたベンゾイミダゾール誘導体を光学的に精製する方法 |
Country Status (36)
| Country | Link |
|---|---|
| US (1) | US5929244A (ja) |
| EP (2) | EP0836601B1 (ja) |
| JP (1) | JP4195507B2 (ja) |
| KR (1) | KR100451078B1 (ja) |
| CN (1) | CN1098261C (ja) |
| AT (1) | ATE418549T1 (ja) |
| AU (1) | AU698638B2 (ja) |
| BR (1) | BR9609450A (ja) |
| CA (1) | CA2226184C (ja) |
| CZ (1) | CZ295430B6 (ja) |
| DE (1) | DE69637788D1 (ja) |
| DK (1) | DK0836601T3 (ja) |
| DZ (1) | DZ2057A1 (ja) |
| EE (1) | EE03444B1 (ja) |
| ES (1) | ES2318850T3 (ja) |
| HR (1) | HRP960232A2 (ja) |
| HU (1) | HUP9901717A3 (ja) |
| IL (1) | IL122811A (ja) |
| IS (1) | IS2666B (ja) |
| MA (1) | MA23921A1 (ja) |
| MY (1) | MY114018A (ja) |
| NO (1) | NO313008B1 (ja) |
| NZ (1) | NZ311842A (ja) |
| PL (1) | PL186702B1 (ja) |
| PT (1) | PT836601E (ja) |
| RS (1) | RS49826B (ja) |
| RU (1) | RU2144031C1 (ja) |
| SA (1) | SA96170103B1 (ja) |
| SI (1) | SI0836601T1 (ja) |
| SK (1) | SK284780B6 (ja) |
| TN (1) | TNSN96090A1 (ja) |
| TR (1) | TR199701754T1 (ja) |
| TW (1) | TW444010B (ja) |
| UA (1) | UA49838C2 (ja) |
| WO (1) | WO1997002261A1 (ja) |
| ZA (1) | ZA965205B (ja) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010511679A (ja) * | 2006-12-04 | 2010-04-15 | シデム ファーマ ソシエテ アノニム | テナトプラゾールカリウム塩のコングロメレート |
| JP2010540413A (ja) * | 2007-08-29 | 2010-12-24 | ユニヴェルシテ・ドゥ・ルーアン | オメプラゾール塩の分割方法 |
| WO2011004387A2 (en) | 2009-06-18 | 2011-01-13 | Matrix Laboratories Ltd | Process for the preparation of dexlansoprazole polymorphic forms |
| EP2281821A1 (en) | 2000-05-15 | 2011-02-09 | Takeda Pharmaceutical Company Limited | Process for producing crystal of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]benzimidazole |
| EP2345650A1 (en) | 2000-12-01 | 2011-07-20 | Takeda Pharmaceutical Company Limited | Amorphous (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole as anti-ulcer agent |
| US8809542B2 (en) | 2000-08-04 | 2014-08-19 | Takeda Pharmaceutical Company Limited | Salts of benzimidazole compound and use thereof |
| WO2016017448A1 (ja) * | 2014-07-30 | 2016-02-04 | 株式会社アエタスファルマ | 1,4-ベンゾチアゼピン-1-オキシド誘導体の光学異性体、及びそれを用いた医薬組成物 |
| JP2018507228A (ja) * | 2015-03-06 | 2018-03-15 | エッフェ・イ・エッセ − ファッブリカ・イタリアーナ・シンテテイチ・ソチエタ・ペル・アツィオーニF.I.S. − Fabbrica Italiana Sintetici S.p.A. | エソメプラゾールの光学精製の改良された方法 |
Families Citing this family (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP960232A2 (en) * | 1995-07-03 | 1998-02-28 | Astra Ab | A process for the optical purification of compounds |
| US6489346B1 (en) * | 1996-01-04 | 2002-12-03 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
| US6699885B2 (en) * | 1996-01-04 | 2004-03-02 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and methods of using same |
| US6645988B2 (en) | 1996-01-04 | 2003-11-11 | Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
| US5840737A (en) | 1996-01-04 | 1998-11-24 | The Curators Of The University Of Missouri | Omeprazole solution and method for using same |
| AU6551198A (en) * | 1997-05-30 | 1998-12-30 | Dr. Reddy's Research Foundation | Novel benzimidazole derivatives as antiulcer agents, process for their preparation and pharmaceutical compositions containing them |
| WO1999038513A1 (en) * | 1998-01-30 | 1999-08-05 | Sepracor Inc. | R-lansoprazole compositions and methods |
| SE9900274D0 (sv) | 1999-01-28 | 1999-01-28 | Astra Ab | New compound |
| TWI275587B (en) | 1999-06-17 | 2007-03-11 | Takeda Chemical Industries Ltd | A crystal of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole |
| ATE298334T1 (de) | 1999-06-30 | 2005-07-15 | Takeda Pharmaceutical | Kristalle von lansoprazole |
| US6369087B1 (en) | 1999-08-26 | 2002-04-09 | Robert R. Whittle | Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
| US6268385B1 (en) | 1999-08-26 | 2001-07-31 | Robert R. Whittle | Dry blend pharmaceutical formulations |
| US6312723B1 (en) | 1999-08-26 | 2001-11-06 | Robert R. Whittle | Pharmaceutical unit dosage form |
| US6326384B1 (en) | 1999-08-26 | 2001-12-04 | Robert R. Whittle | Dry blend pharmaceutical unit dosage form |
| US6312712B1 (en) | 1999-08-26 | 2001-11-06 | Robert R. Whittle | Method of improving bioavailability |
| US6262085B1 (en) | 1999-08-26 | 2001-07-17 | Robert R. Whittle | Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
| US6780880B1 (en) | 1999-08-26 | 2004-08-24 | Robert R. Whittle | FT-Raman spectroscopic measurement |
| US6262086B1 (en) | 1999-08-26 | 2001-07-17 | Robert R. Whittle | Pharmaceutical unit dosage form |
| US6316020B1 (en) | 1999-08-26 | 2001-11-13 | Robert R. Whittle | Pharmaceutical formulations |
| KR100433735B1 (ko) * | 2001-06-27 | 2004-06-04 | 주식회사 씨트리 | 결정형 ⅰ을 갖는 란소프라졸의 제조방법 |
| SE0104295D0 (sv) * | 2001-12-18 | 2001-12-18 | Astrazeneca Ab | New process |
| WO2003063840A2 (en) * | 2002-01-25 | 2003-08-07 | Santarus, Inc. | Transmucosal delivery of proton pump inhibitors |
| WO2004035052A1 (ja) | 2002-10-16 | 2004-04-29 | Takeda Pharmaceutical Company Limited | 安定な固形製剤 |
| MY148805A (en) | 2002-10-16 | 2013-05-31 | Takeda Pharmaceutical | Controlled release preparation |
| DE10254167A1 (de) | 2002-11-20 | 2004-06-09 | Icon Genetics Ag | Verfahren zur Kontrolle von zellulären Prozessen in Pflanzen |
| ES2383679T3 (es) | 2002-12-06 | 2012-06-25 | Nycomed Gmbh | Procedimiento para la preparación de (S)-pantoprazol |
| AR042277A1 (es) | 2002-12-06 | 2005-06-15 | Altana Pharma Ag | Un procedimiento para la preparacion de sulfinil benzimidazoles opticamente puros |
| WO2004073654A2 (en) * | 2003-02-20 | 2004-09-02 | Santarus, Inc. | A novel formulation, omeprazole antacid complex-immediate release for rapid and sustained supression of gastric acid |
| US20060247277A1 (en) * | 2003-02-28 | 2006-11-02 | Yatendra Kumar | Polymorphs of s-omeprazole |
| MXPA06000524A (es) * | 2003-07-18 | 2006-08-11 | Santarus Inc | Formulacion farmaceutica y metodo para tratar desordenes gastrointestinales provocados por acido. |
| US8993599B2 (en) | 2003-07-18 | 2015-03-31 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
| US7005732B2 (en) * | 2003-10-21 | 2006-02-28 | Honeywell International Inc. | Methods and systems for providing MEMS devices with a top cap and upper sense plate |
| FR2863609A1 (fr) * | 2003-12-15 | 2005-06-17 | Isochem Sa | Procede d'enrichissement enantiomerique d'un melange d'enantiomeres d'alpha-aminoacides |
| SE0400410D0 (sv) * | 2004-02-20 | 2004-02-20 | Astrazeneca Ab | New compounds |
| US8815916B2 (en) * | 2004-05-25 | 2014-08-26 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
| US8906940B2 (en) * | 2004-05-25 | 2014-12-09 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
| US8461187B2 (en) | 2004-06-16 | 2013-06-11 | Takeda Pharmaceuticals U.S.A., Inc. | Multiple PPI dosage form |
| FR2876101B1 (fr) * | 2004-10-05 | 2007-03-02 | Sidem Pharma Sa Sa | Procede de preparation enantioselective de derives de sulfoxydes |
| EP1801110A1 (en) | 2005-12-22 | 2007-06-27 | KRKA, tovarna zdravil, d.d., Novo mesto | Esomeprazole arginine salt |
| US7553857B2 (en) | 2005-12-23 | 2009-06-30 | Lek Pharmaceuticals D.D. | S-omeprazole magnesium |
| US7786309B2 (en) * | 2006-06-09 | 2010-08-31 | Apotex Pharmachem Inc. | Process for the preparation of esomeprazole and salts thereof |
| EP1947099A1 (en) | 2007-01-18 | 2008-07-23 | LEK Pharmaceuticals D.D. | Process for solvent removal from omeprazole salts |
| CN101323609B (zh) * | 2007-06-15 | 2013-05-01 | 成都福瑞生物工程有限公司 | 不对称氧化硫醚成亚砜合成对映体含量高的苯并咪唑衍生物的方法 |
| WO2008152462A1 (en) * | 2007-06-15 | 2008-12-18 | Emcure Pharmaceuticals Limited | A process of sulfoxidation of biologically active compounds |
| EA017064B1 (ru) | 2008-03-10 | 2012-09-28 | Такеда Фармасьютикал Компани Лимитед | Кристаллическое производное бензимидазола |
| US8354541B2 (en) | 2008-11-18 | 2013-01-15 | Hetero Research Foundation | Optical purification of esomeprazole |
| KR101001646B1 (ko) * | 2008-12-12 | 2010-12-17 | 한미약품 주식회사 | (r)-(+)-란소프라졸의 제조방법 및 이에 사용되는 중간체 |
| WO2011058569A1 (en) | 2009-11-12 | 2011-05-19 | Hetero Research Foundation | Process for the resolution of omeprazole |
| WO2011092665A1 (en) | 2010-01-29 | 2011-08-04 | Ranbaxy Laboratories Limited | Process for the preparation of crystalline forms of dexlansoprazole |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE7804231L (sv) * | 1978-04-14 | 1979-10-15 | Haessle Ab | Magsyrasekretionsmedel |
| JPS6150978A (ja) * | 1984-08-16 | 1986-03-13 | Takeda Chem Ind Ltd | ピリジン誘導体およびその製造法 |
| AU4640985A (en) * | 1984-08-31 | 1986-03-06 | Nippon Chemiphar Co. Ltd. | Benzimidazole derivatives |
| FI90544C (fi) * | 1986-11-13 | 1994-02-25 | Eisai Co Ltd | Menetelmä lääkeaineina käyttökelpoisten 2-pyridin-2-yyli-metyylitio- ja sulfinyyli-1H-bensimidatsolijohdannaisten valmistamiseksi |
| ATE110069T1 (de) * | 1989-11-29 | 1994-09-15 | Toa Eiyo Ltd | Cycloheptenopyridinderivate, verfahren zu ihrer herstellung und diese enthaltende antiulkusmitteln. |
| DE4035455A1 (de) * | 1990-11-08 | 1992-05-14 | Byk Gulden Lomberg Chem Fab | Enantiomerentrennung |
| SE9301830D0 (sv) * | 1993-05-28 | 1993-05-28 | Ab Astra | New compounds |
| IS4232A (is) * | 1993-12-06 | 1995-06-07 | Astra Aktiebolag | Súbstitúerað bensimidasól, aðferðir við framleiðslu þess og lyfjafræðileg notkun |
| HRP960232A2 (en) * | 1995-07-03 | 1998-02-28 | Astra Ab | A process for the optical purification of compounds |
-
1996
- 1996-05-21 HR HRPCT/SE95/00817A patent/HRP960232A2/hr not_active Application Discontinuation
- 1996-06-19 SA SA96170103A patent/SA96170103B1/ar unknown
- 1996-06-19 RS YUP-376/96A patent/RS49826B/sr unknown
- 1996-06-19 ZA ZA965205A patent/ZA965205B/xx unknown
- 1996-06-22 TW TW085107517A patent/TW444010B/zh not_active IP Right Cessation
- 1996-06-26 PT PT96922339T patent/PT836601E/pt unknown
- 1996-06-26 AT AT96922339T patent/ATE418549T1/de active
- 1996-06-26 CA CA002226184A patent/CA2226184C/en not_active Expired - Lifetime
- 1996-06-26 PL PL96324394A patent/PL186702B1/pl not_active IP Right Cessation
- 1996-06-26 NZ NZ311842A patent/NZ311842A/xx not_active IP Right Cessation
- 1996-06-26 WO PCT/SE1996/000841 patent/WO1997002261A1/en not_active Ceased
- 1996-06-26 UA UA97126300A patent/UA49838C2/uk unknown
- 1996-06-26 IL IL12281196A patent/IL122811A/xx not_active IP Right Cessation
- 1996-06-26 JP JP50506397A patent/JP4195507B2/ja not_active Expired - Lifetime
- 1996-06-26 ES ES96922339T patent/ES2318850T3/es not_active Expired - Lifetime
- 1996-06-26 EP EP96922339A patent/EP0836601B1/en not_active Expired - Lifetime
- 1996-06-26 HU HU9901717A patent/HUP9901717A3/hu not_active Application Discontinuation
- 1996-06-26 DZ DZ960101A patent/DZ2057A1/fr active
- 1996-06-26 CZ CZ19974211A patent/CZ295430B6/cs not_active IP Right Cessation
- 1996-06-26 BR BR9609450A patent/BR9609450A/pt not_active Application Discontinuation
- 1996-06-26 EE EE9700368A patent/EE03444B1/xx not_active IP Right Cessation
- 1996-06-26 CN CN96196465A patent/CN1098261C/zh not_active Expired - Lifetime
- 1996-06-26 KR KR1019970709953A patent/KR100451078B1/ko not_active Expired - Fee Related
- 1996-06-26 SI SI9630766T patent/SI0836601T1/sl unknown
- 1996-06-26 DK DK96922339T patent/DK0836601T3/da active
- 1996-06-26 RU RU98101727A patent/RU2144031C1/ru not_active IP Right Cessation
- 1996-06-26 DE DE69637788T patent/DE69637788D1/de not_active Expired - Lifetime
- 1996-06-26 US US08/676,215 patent/US5929244A/en not_active Expired - Lifetime
- 1996-06-26 SK SK1793-97A patent/SK284780B6/sk not_active IP Right Cessation
- 1996-06-26 TR TR97/01754T patent/TR199701754T1/xx unknown
- 1996-06-26 EP EP04024339A patent/EP1498416A1/en not_active Withdrawn
- 1996-06-26 AU AU63240/96A patent/AU698638B2/en not_active Expired
- 1996-06-28 MA MA24295A patent/MA23921A1/fr unknown
- 1996-07-02 TN TNPCT/SE1995/000817A patent/TNSN96090A1/fr unknown
- 1996-07-03 MY MYPI96002734A patent/MY114018A/en unknown
-
1997
- 1997-01-21 IS IS4638A patent/IS2666B/is unknown
- 1997-12-22 NO NO19976030A patent/NO313008B1/no not_active IP Right Cessation
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2281821A1 (en) | 2000-05-15 | 2011-02-09 | Takeda Pharmaceutical Company Limited | Process for producing crystal of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]benzimidazole |
| US8809542B2 (en) | 2000-08-04 | 2014-08-19 | Takeda Pharmaceutical Company Limited | Salts of benzimidazole compound and use thereof |
| EP2345650A1 (en) | 2000-12-01 | 2011-07-20 | Takeda Pharmaceutical Company Limited | Amorphous (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole as anti-ulcer agent |
| JP2010511679A (ja) * | 2006-12-04 | 2010-04-15 | シデム ファーマ ソシエテ アノニム | テナトプラゾールカリウム塩のコングロメレート |
| JP2010540413A (ja) * | 2007-08-29 | 2010-12-24 | ユニヴェルシテ・ドゥ・ルーアン | オメプラゾール塩の分割方法 |
| WO2011004387A2 (en) | 2009-06-18 | 2011-01-13 | Matrix Laboratories Ltd | Process for the preparation of dexlansoprazole polymorphic forms |
| WO2016017448A1 (ja) * | 2014-07-30 | 2016-02-04 | 株式会社アエタスファルマ | 1,4-ベンゾチアゼピン-1-オキシド誘導体の光学異性体、及びそれを用いた医薬組成物 |
| JPWO2016017448A1 (ja) * | 2014-07-30 | 2017-05-18 | 株式会社アエタスファルマ | 1,4−ベンゾチアゼピン−1−オキシド誘導体の光学異性体、及びそれを用いた医薬組成物 |
| US10071996B2 (en) | 2014-07-30 | 2018-09-11 | Aetas Pharma Co., Ltd. | Optical isomer of 1,4-benzothiazepine-1-oxide derivative, and pharmaceutical composition prepared using same |
| JP2018507228A (ja) * | 2015-03-06 | 2018-03-15 | エッフェ・イ・エッセ − ファッブリカ・イタリアーナ・シンテテイチ・ソチエタ・ペル・アツィオーニF.I.S. − Fabbrica Italiana Sintetici S.p.A. | エソメプラゾールの光学精製の改良された方法 |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH11508590A (ja) | エナンチオマーが富化されたベンゾイミダゾール誘導体を光学的に精製する方法 | |
| JP3795917B2 (ja) | 置換スルホキシドの合成法 | |
| US20100324298A1 (en) | Novel Process for the Preparation of Esomeprazole and Salts Thereof | |
| WO2016142165A1 (en) | Improved process for the optical purification of esomeprazole | |
| HK1010193B (en) | A process for the optical purification of enantiomerically enriched benzimidazole derivatives | |
| MXPA98000160A (en) | A process for the optic purification of derivatives of benzimidazol enriquecidos enantiomericame | |
| HK1008331B (en) | Process for synthesis of substituted sulphoxides |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20070227 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20070215 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20070528 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20070709 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070823 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20080902 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20080926 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20111003 Year of fee payment: 3 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20121003 Year of fee payment: 4 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20121003 Year of fee payment: 4 |
|
| S202 | Request for registration of non-exclusive licence |
Free format text: JAPANESE INTERMEDIATE CODE: R315201 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20121003 Year of fee payment: 4 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20131003 Year of fee payment: 5 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| EXPY | Cancellation because of completion of term |